Origin Materials (ORGN) Q4 2024 earnings summary

Executive summary

• Launched the first commercial PET cap manufacturing line, commencing shipments for customer qualification and marking a shift to technology-driven manufacturing, with commercial production beginning in Q4 2024 and February 2025.

• Strong demand from major brands, with multiple MOUs signed and a sales pipeline exceeding current and near-term supply; commercial products expected on shelves by late Q2 or Q3 2025.

• Origin is first to market with a commercial PET cap, offering improved recyclability, performance, and cost competitiveness.

• Eight CapFormer lines targeted to be online by end of 2025, with additional lines planned for 2026 as capital allows.

• Focused on scaling closures manufacturing, improving margins, and maintaining a healthy cash position through debt financing.

Financial highlights

• Ended 2024 with $103 million in cash, cash equivalents, and securities, down from $158 million at the end of 2023.

• Q4 2024 revenue was $9.2 million, down from $13.1 million in Q4 2023; full-year 2024 revenue was $31.3 million, within guidance.

• Q4 operating expenses were $16.2 million, a decrease of $3.6 million year-over-year, mainly due to lower R&D and G&A expenses.

• Full-year 2024 operating expenses rose to $85.3 million, driven by a $15.2 million non-cash impairment and $7.4 million higher depreciation.

• Q4 net loss was $13.5 million; full-year net loss was $83.7 million.

Outlook and guidance

• Revenue generation from caps business expected to ramp in Q3 2025, with meaningful revenue by Q4 and a strong 2025 exit run rate.

• 2026 revenue projected at $110–$140 million, excluding potential licensing revenue.

• EBITDA positive run rate now expected by end of 2026, updated from prior guidance of first half 2026, due to Line 1 delays.

• No additional equity capital anticipated; debt financing being arranged to fund growth.

• Cap business gross margins anticipated in the mid-double digits, with payback period per line under 18 months.